Key facts
- It has raised $154.7M; the latest was Later Stage VC ($72.5M) in Mar 2026.
- Notable investors include Suzhou Oriza Holdings Corporation, Qiming Venture Partners, OrbiMed, Source Code Capital, SDIC Unity Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for StairMed
- ·The full record, as it builds
Funding rounds
No funding rounds for StairMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About StairMed
Developer of implantable brain-computer interface systems intended for motor control, neurological regulation, and sensory restoration. The company's offerings include implantable electrodes, neural interface components, neurophysiological research tools, electrophysiology instruments and neural monitoring devices, thereby supporting clinical translation and enhancing the understanding and application of brain-computer interface technologies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- stairmed.com/
- Ownership
- Privately Held (backing)
StairMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in StairMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on StairMed in its N-PORT filings yet. We sweep new filings monthly.